loading

Bright Minds Biosciences Inc Stock (DRUG) Forecast

The Bright Minds Biosciences Inc (DRUG) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.3388, representing a -93.95% decrease from the current price of $38.65. The highest analyst price target is $2.3526, and the lowest is $2.325.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DRUG Price Target
Average 1.8103 (-95.32% Downside)
loading

Is Bright Minds Biosciences Inc (DRUG) A Buy Now?

Oscillators
Name Value Action
RSI(14) 49.30 Neutral
STOCH(9,6) 33.84 Neutral
STOCHRSI(14) 14.56 Buy
MACD(12,26) 0.1821 Sell
ADX(14) 25.65 Buy
William %R -79.69 Neutral
CCI(14) -60.20 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
38.85
Sell
39.16
Sell
MA20
39.81
Sell
39.41
Sell
MA50
40.29
Sell
35.01
Buy
MA100
20.71
Buy
25.98
Buy
MA200
10.93
Buy
16.68
Buy
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, DRUG could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on DRUG, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 49.3 indicates that DRUG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 33.84 indicates that DRUG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 14.56 indicates that DRUG is oversold. This suggests that DRUG price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 25.65 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -60.2 indicates that DRUG is still oversold but not to an extreme extent.

Long-term DRUG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Bright Minds Biosciences Inc financial reports and earnings history, Bright Minds Biosciences Inc (DRUG) stock could reach $7.4111 by 2030, $13.39 by 2040 and $34.86 by 2050. See the projected annual prices until 2050 of the Bright Minds Biosciences Inc stock below:

  • Bright Minds Biosciences Inc (DRUG) is expected to reach an average price of $4.6772 in 2035, with a high prediction of $4.6731 and a low estimate of $4.7425. This indicates an $-87.90% rise from the last recorded price of $38.65.
  • Bright Minds Biosciences Inc (DRUG) stock is projected to chart a bullish course in 2040, with an average price target of $13.16, representing an $-65.96% surge from its current level. The forecast ranges from a conservative $13.18 to a sky-high $13.39.
  • Our analysts predict Bright Minds Biosciences Inc (DRUG) to jump -40.71% by 2045, soaring from $23.34 to an average price of $22.91, potentially reaching $23.54. While $23.34 is the low estimate, the potential upside is significant.
  • Bright Minds Biosciences Inc (DRUG) stock is expected to climb by 2050, reaching an average of $35.04, a $-9.35% jump from its current level. However, a wide range of estimates exists, with high and low targets of $34.86 and $35.09, respectively, highlighting the market's uncertainty.

Bright Minds Biosciences Inc Stock (DRUG) Year by Year Forecast

Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2025

Bright Minds Biosciences Inc Stock (DRUG) is expected to reach an average price of $1.8103 in 2025, with a high prediction of $2.3526 and a low estimate of $1.2679. This indicates an -95.32% fall from the last recorded price of $38.65.
Month Average Low High Change from today's price
January, 2025 $2.3719 $2.325 $2.3526 -93.86%
February, 2025 $2.0894 $2.2104 $2.1995 -94.59%
March, 2025 $0.4492 $1.8392 $2.0932 -98.84%
April, 2025 $1.6626 $1.2679 $1.3226 -95.70%
May, 2025 $1.8143 $1.6713 $1.7687 -95.31%
June, 2025 $1.6021 $1.8147 $1.7622 -95.85%
July, 2025 $1.5755 $1.5768 $1.6294 -95.92%
August, 2025 $1.6704 $1.6942 $1.7115 -95.68%
September, 2025 $1.7256 $1.7151 $1.6849 -95.54%
October, 2025 $1.7621 $1.6718 $1.6983 -95.44%
November, 2025 $1.8409 $1.7371 $1.7432 -95.24%
December, 2025 $1.5177 $1.5954 $1.7517 -96.07%

Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2026

The predicted value for Bright Minds Biosciences Inc (DRUG) in 2026 is set at an average of $2.3319. Estimates vary from a peak of $4.656 to a trough of $0.00774, indicating an -93.97% surge from the present price of $38.65.
Month Average Low High Change from today's price
January, 2026 $1.4201 $1.5701 $1.5025 -96.33%
February, 2026 $1.3611 $1.4358 $1.397 -96.48%
March, 2026 $1.7894 $1.3617 $2.2594 -95.37%
April, 2026 $0.586 $0.546 $4.656 -98.48%
May, 2026 $0.4813 $0.34 $1.0673 -98.75%
June, 2026 $0.0134 $0.0641 $0.5426 -99.97%
July, 2026 $0.1568 $0.0994 $0.1218 -99.59%
August, 2026 $0.0615 $0.1854 $0.1055 -99.84%
September, 2026 $0.184 $0.00774 $0.3741 -99.52%
October, 2026 $0.706 $0.1264 $0.929 -98.17%
November, 2026 $0.7656 $0.5917 $1.2456 -98.02%
December, 2026 $0.5223 $0.4024 $1.0783 -98.65%

Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Bright Minds Biosciences Inc (DRUG) is $2.9259, with a high forecast of $5.789 and a low forecast of $0.0628. This indicates an -92.43% decrease from the last price of $38.65.
Month Average Low High Change from today's price
January, 2027 $0.2175 $0.1162 $0.6536 -99.44%
February, 2027 $0.0978 $0.0628 $0.4108 -99.75%
March, 2027 $3.9371 $0.1141 $3.4951 -89.81%
April, 2027 $4.4915 $4.1293 $4.2042 -88.38%
May, 2027 $5.061 $4.6589 $4.9809 -86.91%
June, 2027 $5.0177 $5.0283 $4.9783 -87.02%
July, 2027 $5.641 $5.1551 $5.3172 -85.40%
August, 2027 $5.4866 $5.5192 $5.4292 -85.80%
September, 2027 $5.7483 $5.674 $5.789 -85.13%
October, 2027 $5.5878 $5.5155 $5.5031 -85.54%
November, 2027 $5.5826 $5.5801 $5.5123 -85.56%
December, 2027 $5.174 $5.295 $5.5224 -86.61%

Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2028

In 2028, Bright Minds Biosciences Inc (DRUG) is projected to reach an average price of $4.284, with a high projection of $5.1564 and a low estimate of $3.4116. This indicates an -88.92% fall from the last price of $38.65.
Month Average Low High Change from today's price
January, 2028 $3.4485 $4.8385 $5.1564 -91.08%
February, 2028 $4.3279 $4.2459 $4.0779 -88.80%
March, 2028 $4.6216 $4.5427 $4.5974 -88.04%
April, 2028 $4.3242 $4.5742 $4.5321 -88.81%
May, 2028 $4.191 $4.2136 $4.3089 -89.16%
June, 2028 $4.2006 $4.2883 $4.263 -89.13%
July, 2028 $4.1705 $4.1842 $4.1677 -89.21%
August, 2028 $4.1004 $4.0527 $4.0672 -89.39%
September, 2028 $4.094 $4.0541 $4.0087 -89.41%
October, 2028 $3.7565 $3.9329 $3.9834 -90.28%
November, 2028 $3.4813 $3.6323 $3.6428 -90.99%
December, 2028 $3.3369 $3.4116 $3.4368 -91.37%

Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2029

The 2029 price forecast for Bright Minds Biosciences Inc Stock (DRUG) is $1.7435 on average, with a high prediction of $3.2564 and a low estimate of $0.2306. This represents an -95.49% decrease from the previous price of $38.65.
Month Average Low High Change from today's price
January, 2029 $0.3485 $0.513 $3.2564 -99.10%
February, 2029 $1.1979 $0.2306 $2.8721 -96.90%
March, 2029 $1.2174 $1.0027 $1.1974 -96.85%
April, 2029 $1.6268 $1.4947 $1.4694 -95.79%
May, 2029 $1.6636 $1.6489 $1.6286 -95.70%
June, 2029 $1.483 $1.613 $1.591 -96.16%
July, 2029 $1.1725 $1.3116 $1.3078 -96.97%
August, 2029 $0.5237 $0.5592 $1.0498 -98.65%
September, 2029 $0.3787 $0.3213 $0.4166 -99.02%
October, 2029 $0.5155 $0.3581 $0.2681 -98.67%
November, 2029 $0.7349 $0.7829 $0.7177 -98.10%
December, 2029 $0.7694 $0.6623 $0.6044 -98.01%

Bright Minds Biosciences Inc Stock (DRUG) Price Forecast for 2030

Bright Minds Biosciences Inc Stock (DRUG) is expected to reach an average price of $4.9519 in 2030, with a high forecast of $9.1721 and a low forecast of $0.7317. This signifies an -87.19% decrease from the last price of $38.65.
Month Average Low High Change from today's price
January, 2030 $7.8531 $0.7317 $7.4111 -79.68%
February, 2030 $8.3223 $8.0241 $8.0562 -78.47%
March, 2030 $8.8065 $8.4683 $8.7264 -77.21%
April, 2030 $8.7006 $8.7106 $8.7025 -77.49%
May, 2030 $9.1946 $8.7726 $8.8708 -76.21%
June, 2030 $8.9549 $9.0089 $8.9328 -76.83%
July, 2030 $9.11 $9.121 $9.1721 -76.43%
August, 2030 $8.8643 $8.8132 $8.8222 -77.07%
September, 2030 $8.7737 $8.8134 $8.7034 -77.30%
October, 2030 $8.2585 $8.3795 $8.6922 -78.63%
November, 2030 $6.4477 $7.8377 $8.2196 -83.32%
December, 2030 $7.2419 $7.2238 $6.9919 -81.26%
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Cap:     |  Volume (24h):